Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editors Cut Session
| IBX50 Index | 21,724 161.04 0.75% |
Under 52% of Bovespa Brazil's investor base is interested to short. The analysis of the overall investor sentiment regarding Bovespa Brazil 50 suggests that many traders are impartial. Bovespa Brazil's investing sentiment shows overall attitude of investors towards Bovespa Brazil 50.
Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced the publication and discussion of a manuscript Oral LPCN 1148 Improves Sarcopenia and Hepatic Encephalopathy in Male Patients with Cirrhosis a randomized, placebo-controlled Phase 2 trial in the journal Hepatology and discussion at The Liver Meeting 2024 Editors Cut Clinical Study Session held on November 16
Read at finance.yahoo.com
 |
Bovespa Brazil 50 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bovespa Brazil index to make a market-neutral strategy. Peer analysis of Bovespa Brazil could also be used in its relative valuation, which is a method of valuing Bovespa Brazil by comparing valuation metrics with similar companies.
Peers
Bovespa Brazil Related Equities
| NTGR | NETGEAR | 3.76 | ||||
| FNKO | Funko | 0.70 | ||||
| FKWL | Franklin Wireless | 0.23 | ||||
| MBOT | Microbot Medical | 0.99 | ||||
| SONO | Sonos | 2.42 | ||||
| SPHR | Sphere Entertainment | 2.57 | ||||
| ANPDY | ANTA Sports | 5.29 |